文献速递外周动脉疾病

CLTI患者治疗多支胫动脉与更少重大再干预相关

Treating More Than One Tibial Artery in Patients with Chronic Limb Threatening Ischaemia is Associated with Fewer Major Re-interventions.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2026-07-22

本研究基于BEST-CLI试验的血管腔内数据集进行回顾性按治疗分析,比较单支动脉干预(SAI)与多支动脉干预(MAI)在弥漫性胫动脉闭塞性疾病中的效果。共纳入324例患者(SAI 224例,MAI 100例)。风险校正分析显示,SAI与MAI相比重大再干预率更高(OR 3.14,95%CI 1.2-8.2;结论提示在指数血运重建时治疗多支胫动脉而非仅一支与更少的重大再干预相关,应考虑采用。

要点

  • 在弥漫性胫动脉闭塞病患者中,多支动脉干预与更少重大再干预相关。
  • 风险校正后,单支动脉干预的重大再干预风险是多支干预的3.14倍。
  • 两组在MALE或死亡、踝上截肢、症状缓解及死亡方面无显著差异。

核心结论

  • 在弥漫性胫动脉闭塞性疾病患者中,指数血运重建时治疗多支胫动脉而非仅一支与更少的重大再干预相关,应考虑采用。

研究设计与样本

  • 回顾性、按治疗分析,基于BEST-CLI试验的血管腔内数据集,比较单支动脉干预(SAI)与多支动脉干预(MAI)。
  • 仅纳入多支胫动脉闭塞性疾病且狭窄>50%的患者,共324例(SAI 224例,MAI 100例),并进行风险校正分析。

临床怎么用

  • 对于弥漫性胫动脉闭塞性CLTI患者,在指数血运重建时可考虑治疗多支胫动脉以减少重大再干预。
  • 决策时需权衡多支干预的获益与风险,并考虑患者个体情况。

局限性

  • 回顾性、按治疗分析,可能存在选择偏倚。
  • 样本量有限(324例),MAI组仅100例。
  • 基于BEST-CLI试验的血管腔内数据集,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: It is unclear whether treating multiple diseased tibial arteries at initial revascularisation improves outcomes for chronic limb threatening ischaemia (CLTI). Using data from the Best Endovascular versus Best Surgical Therapy in Patients with CLTI (BEST-CLI) trial this study aimed to compare single arterial intervention (SAI) with multiple arterial intervention (MAI) for infrapopliteal disease. METHODS: A retrospective, as treated analysis of the endovascular dataset from the BEST-CLI trial was undertaken to compare SAI with MAI. Only patients with multiple tibial vessel arterial occlusive disease with > 50% stenosis were included. Evaluated outcomes included major re-interventions (new bypass, interposition graft, thrombectomy, or thrombolysis), major adverse limb events (MALE) or death, and above ankle amputations. Risk adjusted analysis was performed. RESULTS: There were 324 patients included: 224 SAI and 100 MAI. On unadjusted analysis at 3 years, SAI had a higher rate of a major re-intervention (19.2% vs. 5.3%; p = .010) and MALE or death (56.4% vs. 43.6%; p = .030), while there was no difference for above ankle amputation (19.7% vs. 13.1%; p = .14), amputation or death (45.2% vs. 43%; p = .53), or all cause death (37.7% vs. 33.5%, p = .57). SAI and MAI were associated with similar rates of resolution of initial CLTI symptoms (75.9% vs. 86%; p = .60). On risk adjusted analysis, SAI was associated with a higher rate of major re-intervention (odds ratio [OR] 3.14, 95% confidence interval [CI] 1.2 - 8.2; p = .019) than MAI; however, there was no increase in any re-intervention (OR 0.95, 95% CI 0.6 - 1.49; p = .80), MALE or death (OR 1.27, 95% CI 0.86 - 1.89; p = .24), above ankle amputation (OR 1.53, 95% CI 0.74 - 3.19; p = .25), initial CLTI resolution (OR 1.16, 95% CI 0.85 - 1.59; p = .36), or death (OR 1.03, 95% CI 0.64 - 1.63; p = .90). CONCLUSION: In patients with diffuse tibial arterial occlusive disease, treatment of multiple tibial arteries rather than just one at the time of index revascularisation was associated with fewer major re-interventions and should be considered.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Menard MT, Siracuse JJ, Rosenfield K, et al. Treating More Than One Tibial Artery in Patients with Chronic Limb Threatening Ischaemia is Associated with Fewer Major Re-interventions. Eur J Vasc Endovasc Surg. 2026. PMID: 42486324. doi:10.1016/j.ejvs.2026.07.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。